HCPLive® peer-to-peer panel discussions feature authoritative insights, opinions, and perspectives on important issues facing today's cancer care professionals.
Advances in Oral Systemic Treatments for Management of Atopic Dermatitis
September 4th 2024Raj Chovatiya, MD, PhD, MSCI; George Han, MD; Elizabeth (Lisa) Swanson, MD; and Peter Lio, MD, explore the latest advances in oral systemic treatments for atopic dermatitis, including the use and long-term safety of oral JAK inhibitors, strategies for switching therapies, and navigating treatment breaks.
Iron Deficiency Anemia Across Specialties: Optimizing Patient Outcomes through Collaborative Care
July 15th 2024A panel of experts on iron deficiency anemia has a comprehensive discussion on the clinical utilization of intravenous iron, highlighting available products and clinical practices on administration and monitoring.
Emerging Pathways in COPD: Targeting Inflammation for A Tailored Treatment Approach
May 14th 2024Experts on chronic obstructive pulmonary disease (COPD) have a comprehensive discussion on treatment practices, with a focus on emerging pathways and the role of type 2 inflammation in patients with the disease.
Simplifying HIV Treatment in the Presence of Drug Resistance; Preventing from the Start
May 8th 2024A panel of experts discuss simplified treatment approaches for HIV, highlighting the role of the primary care and advanced practice provider, the importance of early treatment initiation, and ways to manage drug resistance.
Identifying Hypercortisolism in Patients with Resistant Diabetes
April 8th 2024Hanford Yau, MD, Ralph DeFronzo, MD, Pam Kushner, MD, Honey East, MD, and Christopher Lucci, MD, discuss the challenges of managing patients with resistant diabetes, emphasizing key strategies for identifying and treatingunderlying hypercortisolismthat leads to resistant diabetes.
Optimizing Outcomes When Using Biologics for Treatment of Psoriasis
March 29th 2024Experts extensively review the array of psoriasis treatments, from topicals to biologics, exploring the landscape of IL therapies and their enhanced safety and efficacy compared to previous agents. The physicians also highlight how common comorbidities may impact on treatment decisions.
Transforming Retinal Disease Management with Novel Therapies
March 21st 2024A panel of ophthalmologists and vitreoretinal specialists discuss treatments for retinal diseases, specifically neovascular age-related macular degeneration (nAMD) and diabetic macular edema (DME). Experts highlight two new therapies, aflibercept 8 mg and faricimab, and how the addition of biosimilars and gene therapy are changing the landscape of care for the better.
Optimizing Treatment of Psoriasis in Patients with Skin of Color
March 7th 2024Leading dermatologists discuss management of psoriasis in patients with skin of color, including disease presentation, cultural stigma and its impact on patient’s quality of life. They also share recently presented and published data, highlighting use of biologics for treatment of psoriasis in patients with skin of color.
Dual-Orexin Receptor Antagonists for Treatment of Insomnia
December 21st 2023In an upcoming Peer Exchange program entitled “Dual-Orexin Receptor Antagonists for Treatment of Insomnia” Dr Paul Doghramji will moderate a conversation with physicians about this class of agents for treatment of insomnia and discuss other therapeutic advancements in the field.
JAK Inhibitors in the Evolving Treatment Landscape of Atopic Dermatitis
November 16th 2023Expert dermatologists discuss the use of Janus kinase (JAK) inhibitors for the treatment of atopic dermatitis (AD). They review the nuances of currently approved JAK inhibitors, share treatment considerations for AD, and discuss utilizing JAK inhibitors in clinical practice.
Curing your Patients from Hepatitis C: Addressing Complex Needs with Simplified Treatment Approaches
November 14th 2023A straight forward approach to taking care of patients with Hepatitis C. Experts in the field are offering a simplified overview for new providers on the who, what, where and when of hepatitis C care, as well as practical tips for treatment implementation
Addressing Patient Needs in Seborrheic Dermatitis with Novel Therapies
November 7th 2023Dermatologists discuss the burdens, unmet needs, and emerging treatment options for patients with seborrheic dermatitis, offering clinical insights on therapeutic approaches and the importance of patient-centered care.
New Guidance, New Data and New Targets for the Management of Hyperlipidemia
September 7th 2023Expert cardiologists discuss strategies to improve control of LDL-cholesterol in high-risk individuals as well as real world data on reaching LDL-cholesterol thresholds. They will cover emerging therapies for lipid lowering and strategies to help implement lipid lowering therapies into your clinical practice.
Delaying the Onset of Type 1 Diabetes Through Early Intervention
July 19th 2023Expert endocrinologists explore the pathophysiology of type 1 diabetes (T1D) and delve into screening and staging processes. They discuss strategies for delaying its onset and provide insight into the future of T1D management.
Understanding Fibromyalgia; How Experts are Diagnosing and Treating Their Patients
June 21st 2023Experts present the current landscape of treatment for patients with fibromyalgia (FM), highlighting its pathophysiology and risk factors, the importance of integrative care, and three recent FDA agents approved for treatment.
Emerging Evidence to Guide Patient-Centric Treatment Selection for Heart Failure
June 13th 2023An expert panel discusses new evidence to guide personalized care in heart failure. They focus on updates in the most recent heart failure guidelines, review guideline-directed medical therapy, and discuss the new clinical trial data in specific patient populations.
Advances in Treatment of Primary Biliary Cholangitis (PBC)
June 7th 2023Experts in hepatology discuss recent updates in primary biliary cholangitis (PBC) treatment and monitoring. They review recently published real-world data and share their approach to personalizing treatment and what is on the horizon for PBC care.
Biologics Treatment Selection in Patients With Moderate-to-Severe Asthma
June 5th 2023A panel of experts discuss the role of type 2 inflammation in asthma, challenges with long-term use of corticosteroids, and the emerging role of biologics and various mechanisms of actions in the management of asthma.